QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
Clinical trial NCT06716970 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06716970
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-04-30
- Enrollment
- 810
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.